These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24986448)

  • 1. Low-protein diet for diabetic nephropathy.
    Otoda T; Kanasaki K; Koya D
    Curr Diab Rep; 2014; 14(9):523. PubMed ID: 24986448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials.
    Zhu HG; Jiang ZS; Gong PY; Zhang DM; Zou ZW; Qian-Zhang ; Ma HM; Guo ZG; Zhao JY; Dong JJ; Lin-Liao
    Lipids Health Dis; 2018 Jun; 17(1):141. PubMed ID: 29914534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A very-low-protein diet ameliorates advanced diabetic nephropathy through autophagy induction by suppression of the mTORC1 pathway in Wistar fatty rats, an animal model of type 2 diabetes and obesity.
    Kitada M; Ogura Y; Suzuki T; Sen S; Lee SM; Kanasaki K; Kume S; Koya D
    Diabetologia; 2016 Jun; 59(6):1307-17. PubMed ID: 27020449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-protein diet supplemented with ketoacids delays the progression of diabetic nephropathy by inhibiting oxidative stress in the KKAy mice model.
    Liu D; Wu M; Li L; Gao X; Yang B; Mei S; Fu L; Mei C
    Br J Nutr; 2018 Jan; 119(1):22-29. PubMed ID: 29208058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.
    Jacobsen P; Rossing K; Parving HH
    Curr Opin Nephrol Hypertens; 2004 May; 13(3):319-24. PubMed ID: 15073491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein restriction for diabetic renal disease.
    Robertson L; Waugh N; Robertson A
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD002181. PubMed ID: 17943769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Low-Protein Diet for Diabetic Kidney Disease: Its Effect and Molecular Mechanism, an Approach from Animal Studies.
    Kitada M; Ogura Y; Monno I; Koya D
    Nutrients; 2018 Apr; 10(5):. PubMed ID: 29702558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine abrogates the renoprotective effect of a low-protein diet against diabetic kidney disease in obese rats with type 2 diabetes.
    Kitada M; Ogura Y; Monno I; Xu J; Koya D
    Aging (Albany NY); 2020 Mar; 12(5):4489-4505. PubMed ID: 32145700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low-protein diet in diabetic nephropathy: a meta-analysis of randomized controlled trials.
    Li XF; Xu J; Liu LJ; Wang F; He SL; Su Y; Dong CP
    Lipids Health Dis; 2019 Apr; 18(1):82. PubMed ID: 30935396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of type 2 diabetic nephropathy by blockade of the renin-angiotensin system: a comparison of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonists.
    Hsueh WA
    Curr Opin Pharmacol; 2002 Apr; 2(2):182-8. PubMed ID: 11950631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a low-protein diet supplemented with ketoacids on skeletal muscle atrophy and autophagy in rats with type 2 diabetic nephropathy.
    Huang J; Wang J; Gu L; Bao J; Yin J; Tang Z; Wang L; Yuan W
    PLoS One; 2013; 8(11):e81464. PubMed ID: 24303049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy.
    Facchini FS; Saylor KL
    Diabetes; 2003 May; 52(5):1204-9. PubMed ID: 12716753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein restriction for diabetic renal disease.
    Waugh NR; Robertson AM
    Cochrane Database Syst Rev; 2000; (2):CD002181. PubMed ID: 10796869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.
    Parving HH; Andersen S; Jacobsen P; Christensen PK; Rossing K; Hovind P; Rossing P; Tarnow L
    Semin Nephrol; 2004 Mar; 24(2):147-57. PubMed ID: 15017527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Et and diabetic nephropathy: preclinical and clinical studies.
    Gagliardini E; Zoja C; Benigni A
    Semin Nephrol; 2015 Mar; 35(2):188-96. PubMed ID: 25966350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
    Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
    Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.